Sakemi S, Inagaki T, Kaneda K, Hirai H, Iwata E, Sakakibara T, Yamauchi Y, Norcia M, Wondrack L M, Sutcliffe J A
Central Research Division, Pfizer Pharmaceuticals Inc., Aichi, Japan.
J Antibiot (Tokyo). 1995 Feb;48(2):134-42. doi: 10.7164/antibiotics.48.134.
A fermentation broth of an unidentified fungus (N983-46) was found to produce DNA gyrase inhibitors, CJ-12,371 (1) and CJ-12,372 (2). Following isolation by solvent extraction and silica gel and ODS (reverse phase) chromatographies, the structures were determined to be novel spiro-ketal compounds with S-configuration at position C-1. CJ-12,371 and CJ-12,372 inhibit both DNA supercoiling and relaxation mediated by Escherichia coli DNA gyrase. The interaction of these compounds with DNA gyrase appears to be novel in that the compounds inhibit supercoiling and relaxation without blocking religation; thus, no cleavage intermediate of double strand DNA is observed. Both compounds have antibacterial activity against several species of pathogenic Gram-positive bacteria, with MICs between 25 and 100 micrograms/ml. These results suggest that the antibacterial potency of CJ-12,371 and CJ-12,372 is attributed to the inhibition of DNA gyrase. However, the compounds did not inhibit DNA gyrase selectively, as they also inhibited eukaryotic topoisomerase II-mediated relaxation. Semi-synthetic modifications to the dihydroxy motif in CJ-12,371 altered both gyrase- and topoisomerase II-inhibitory activities, but did not enhance selectivity.
一种未鉴定真菌(N983 - 46)的发酵液被发现能产生DNA促旋酶抑制剂CJ - 12,371(1)和CJ - 12,372(2)。通过溶剂萃取以及硅胶和ODS(反相)色谱法分离后,确定其结构为在C - 1位具有S - 构型的新型螺环缩酮化合物。CJ - 12,371和CJ - 12,372既能抑制大肠杆菌DNA促旋酶介导的DNA超螺旋化,也能抑制其介导的DNA松弛。这些化合物与DNA促旋酶的相互作用似乎很新颖,因为它们在不阻断再连接的情况下抑制超螺旋化和松弛;因此,未观察到双链DNA的切割中间体。这两种化合物对几种致病性革兰氏阳性菌均具有抗菌活性,最低抑菌浓度(MIC)在25至100微克/毫升之间。这些结果表明,CJ - 12,371和CJ - 12,372的抗菌效力归因于对DNA促旋酶的抑制作用。然而,这些化合物并没有选择性地抑制DNA促旋酶,因为它们也抑制真核拓扑异构酶II介导的松弛。对CJ - 12,371中二羟基基序进行半合成修饰,改变了促旋酶和拓扑异构酶II的抑制活性,但并未提高选择性。